Who is sponsoring NCT05907109?

NCT05907109 is sponsored by Instituto de Cardiologia do Rio Grande do Sul.

What condition does NCT05907109 study?

NCT05907109 studies Congenital Heart Disease, Child Development, Early Intervention.

Is NCT05907109 still recruiting?

NCT05907109 is currently status unknown. Last updated 18 June 2023.

Last reviewed 2023-06-18 · How we verify

NCT05907109

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

NeuroCardio Baby Research Outpatient Clinic: Study on the Neurodevelopment of Infants With Congenital Heart Disease in Brazil

Status unknown NA Last updated 18 June 2023

What this trial tests

NA trial testing Remotely monitored parent-mediated hybrid home and clinic based multidisciplinary Early Intervention protocols. in Congenital Heart Disease in 300 participants. Status unknown.

Timeline

16 March 2021

Primary endpoint
31 December 2024

31 December 2025

Quick facts

Lead sponsor	Instituto de Cardiologia do Rio Grande do Sul
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	300
Start date	16 March 2021
Primary completion	31 December 2024
Estimated completion	31 December 2025
Sites	2 locations across Brazil

Drugs / interventions tested

Remotely monitored parent-mediated hybrid home and clinic based multidisciplinary Early Intervention protocols.

Conditions studied

Congenital Heart Disease — all drugs for Congenital Heart Disease →
Child Development — all drugs for Child Development →
Early Intervention — all drugs for Early Intervention →

Sponsor

Instituto de Cardiologia do Rio Grande do Sul — full company profile →

Who can join

Under 2 Months, any sex, with Congenital Heart Disease or Child Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this randomized clinical trial is to test the effectiveness of a low-cost hybrid remotely monitored parent-mediated and clinic-based multidisciplinary early intervention (EI) for low-income infants with CHD in Brazil. The intervention protocols will be administered according to age modules, families will be monitored weekly. High risk infants also receive supplemental clinic-based interventions according to developmental needs. Controls will receive standard of care and access to early child development and nutrition practices information from the Brazilian Ministry of Health. All infants will be evaluated at within a 42-month follow-up research outpatient clinic, called NeuroCardio Baby at Santo Antonio Pediatric Hospital, of the Santa Casa de Misericordia Hospital Complex, and affiliated with The Cardiology Institute-University Foundation of Cardiology (IC-FUC), Porto Alegre, Brazil.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The molecular mechanisms of cardiac development and related diseases.
Li Y, Du J, Deng S, Liu B, et al · · 2024 · cited 53× · PMID 39715759 · DOI 10.1038/s41392-024-02069-8
A remote parent-led early intervention protocol to promote motor development in infants with congenital heart disease: a feasibility pilot study of a randomized clinical trial.
Michelon RC, Lucchese-Lobato F. · · 2024 · cited 1× · PMID 38922306 · DOI 10.1080/17518423.2024.2365796

Verify or expand the search:

Other recruiting trials for Congenital Heart Disease

Currently open trials in the same condition.

NCT07193719 — Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children · Phase 1, PHASE2 · recruiting
NCT07023367 — Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents · NA · recruiting
NCT06833320 — Propranolol Treatment for Postoperative Chylothorax · Phase 1, PHASE2 · recruiting
NCT06668389 — Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary · Phase 4 · recruiting
NCT06872320 — The Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease · NA · active not recruiting

Other Instituto de Cardiologia do Rio Grande do Sul trials

Trials by the same sponsor.

NCT06917729 — Breathing Exercises of CardioBreath Application on Autonomic and Vascular Function in Hypertension · NA · not yet recruiting
NCT06497946 — Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women · NA · recruiting
NCT06282302 — Effect of Isometric and Aerobic Physical Exercise on Blood Pressure Levels in Hypertensive Elderly People · NA · unknown
NCT06139653 — CardioBreathApp vs IMT in Heart Failure · NA · completed
NCT03672760 — Inspiratory Muscle Training X CardioBreath App Effects On Vagal Modulation And Pulse Wave Velocity · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05907109 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto de Cardiologia do Rio Grande do Sul
Last refreshed: 18 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05907109.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing